Literature DB >> 26371815

Decreased Cytotoxic T-Lymphocyte Antigen 4 Expression on Regulatory T Cells and Th17 Cells in Sarcoidosis: Double Trouble?

Caroline E Broos1, Menno van Nimwegen1, Johannes C C M In 't Veen2, Henk C Hoogsteden1, Rudi W Hendriks1, Bernt van den Blink1, Mirjam Kool1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26371815     DOI： 10.1164/rccm.201503-0635LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  12 in total

Review 1.  Potential immunotherapies for sarcoidosis.

Authors:  Van Le; Elliott D Crouser
Journal:  Expert Opin Biol Ther       Date:  2018-01-17       Impact factor: 4.388

2.  Immune-Checkpoint Expression on CD4, CD8 and NK Cells in Blood, Bronchoalveolar Lavage and Lymph Nodes of Sarcoidosis.

Authors:  Miriana d'Alessandro; Laura Bergantini; Fabrizio Mezzasalma; Dalila Cavallaro; Sara Gangi; Stefano Baglioni; Martina Armati; Marta Abbritti; Stefano Cattelan; Paolo Cameli; Elena Bargagli
Journal:  Mol Diagn Ther       Date:  2022-06-27       Impact factor: 4.476

3.  Sarcoid-like Granulomatosis Associated with Immune Checkpoint Inhibitors in Melanoma.

Authors:  Audrey Melin; Émilie Routier; Séverine Roy; Pauline Pradere; Jerome Le Pavec; Thibaut Pierre; Noémie Chanson; Jean-Yves Scoazec; Olivier Lambotte; Caroline Robert
Journal:  Cancers (Basel)       Date:  2022-06-14       Impact factor: 6.575

Review 4.  Immunopathogenesis of granulomas in chronic autoinflammatory diseases.

Authors:  Wilhelmina Maria Cornelia Timmermans; Jan Alexander Michael van Laar; Petrus Martinus van Hagen; Menno Cornelis van Zelm
Journal:  Clin Transl Immunology       Date:  2016-12-16

5.  Mass Cytometry Identifies Distinct Lung CD4+ T Cell Patterns in Löfgren's Syndrome and Non-Löfgren's Syndrome Sarcoidosis.

Authors:  Ylva Kaiser; Tadepally Lakshmikanth; Yang Chen; Jaromir Mikes; Anders Eklund; Petter Brodin; Adnane Achour; Johan Grunewald
Journal:  Front Immunol       Date:  2017-09-12       Impact factor: 7.561

Review 6.  Rheumatic Manifestations in Patients Treated with Immune Checkpoint Inhibitors.

Authors:  Konstantinos Melissaropoulos; Kalliopi Klavdianou; Alexandra Filippopoulou; Fotini Kalofonou; Haralabos Kalofonos; Dimitrios Daoussis
Journal:  Int J Mol Sci       Date:  2020-05-11       Impact factor: 5.923

7.  Safety and efficacy of abatacept in patients with treatment-resistant SARCoidosis (ABASARC) - protocol for a multi-center, single-arm phase IIa trial.

Authors:  Björn C Frye; Ina Caroline Rump; Annette Uhlmann; Fabian Schubach; Gabriele Ihorst; Bodo Grimbacher; Gernot Zissel; Joachim Müller Quernheim
Journal:  Contemp Clin Trials Commun       Date:  2020-05-29

Review 8.  Key Players and Biomarkers of the Adaptive Immune System in the Pathogenesis of Sarcoidosis.

Authors:  Emily-Rose Zhou; Sergio Arce
Journal:  Int J Mol Sci       Date:  2020-10-07       Impact factor: 5.923

9.  Involvement of Dendritic Cells and Th17 Cells in Induced Tertiary Lymphoid Structures in a Chronic Beryllium Disease Mouse Model.

Authors:  Alex KleinJan; Menno van Nimwegen; Karolina Leman; Ke-Xin Wen; Louis Boon; Rudi W Hendriks
Journal:  Mediators Inflamm       Date:  2021-05-06       Impact factor: 4.711

Review 10.  T Follicular Helper Cells As a New Target for Immunosuppressive Therapies.

Authors:  Lin Yan; Kitty de Leur; Rudi W Hendriks; Luc J W van der Laan; Yunying Shi; Lanlan Wang; Carla C Baan
Journal:  Front Immunol       Date:  2017-11-07       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.